跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clariscan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clariscan
Approved
STANDARD
Clariscan
GE Healthcare AS - Oslo Plant
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4602991116cb0e1e
Company
GE Healthcare AS - Oslo Plant
Type
Standard
Approval Details
Approval Id
4602991116cb0e1e
Drug Approval Philippines Name
Clariscan
Product Name
Clariscan
Registration Number
DR-XY48714
Brand Name
Clariscan
Generic Name
Gadoteric Acid
Dosage Form
Solution for Injection (I.V.)
Dosage Strength
0.5 mmol/mL (equivalent to 279.32 mg/mL)
Manufacturer
GE Healthcare AS - Oslo Plant
Importer
A. Menarini Philippines, Inc.
Distributor
A. Menarini Philippines, Inc.
Issuance Date
28 April 2023
Expiry Date
28 April 2028
Pharmacologic Category
Paramagnetic Contrast Media
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4602991116cb0e1e
Type
Standard
Back to Philippines FDA Approvals